Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Increase in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 411,143 shares, an increase of 4,427.0% from the May 14th total of 9,082 shares. Approximately 21.8% of the company’s stock are sold short. Based on an average daily volume of 6,750,071 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, May 21st. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Arcadia Biosciences currently has an average rating of “Sell”.

Arcadia Biosciences Trading Down 1.8%

NASDAQ RKDA opened at $0.90 on Thursday. Arcadia Biosciences has a 12 month low of $0.80 and a 12 month high of $6.71. The stock has a market cap of $1.86 million, a P/E ratio of -0.16 and a beta of 0.51. The stock’s fifty day moving average price is $1.10 and its 200-day moving average price is $1.96.

Arcadia Biosciences (NASDAQ:RKDA) last released its earnings results on Thursday, May 14th. The basic materials company reported ($2.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). Arcadia Biosciences had a negative return on equity of 113.73% and a negative net margin of 195.94%.The company had revenue of $1.10 million during the quarter, compared to analysts’ expectations of $1.60 million.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.